A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 31/137 (2006.01)
Patent
CA 2318920
Methods and compositions are disclosed utilizing the optically pure (-)-isomer of bupropion, which is a potent drug for treating depression, Parkinson's disease, obesity, weight gain, bipolar disorders, attention-deficit disorders, conduct disorders, phycho-sexual dysfunction, bulimia, eating disorders or specific food craving. The composition can be administered intravenously, transdermally (patch) or orally, possibily in a sustained release form.
La présente invention concerne des procédés et des compositions dans lesquels on utilise l'(-)-isomère optiquement pur de buproprion, qui est un médicament actif pour traiter la dépression, la maladie de Parkinson, l'obésité, le gain de poids, les troubles déficitaires de l'attention, les troubles bipolaires, le dysfonctionnement psychosexuel, la boulimie, les troubles de l'alimentation ou la fringale d'aliments spécifiques. On peut administrer cette composition de manière intraveineuse, transdermique (timbre) ou oralement, éventuellement sous forme à libération prolongée.
Osler Hoskin & Harcourt Llp
Sepracor Inc.
LandOfFree
Pharmaceutical uses of optically pure (-)-bupropion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical uses of optically pure (-)-bupropion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical uses of optically pure (-)-bupropion will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1553557